InvestorsHub Logo
Followers 3
Posts 968
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Sunday, 08/23/2020 6:02:32 PM

Sunday, August 23, 2020 6:02:32 PM

Post# of 9135
Everyone thinks it will be JNJ or Roche to buyout Halozyme. However with the current agreement which includes 11 therapeutics slated to use Enhanze (https://www.halozyme.com/enhanze/pipeline/default.aspx), no one should be surprised if BMS steals Halozyme away from the other two big pharma.
From the latest quarterly earnings call, big name/category candidates are:
Ipilimumab (BMS)
Nivolumab (BMS)
Anti-CD73 (BMS)
Relatlimab (BMS)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News